Lawrence Lau
Transplant Surgery · Manhasset, NYNPI 1477102234
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 93.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $8,854 and has fallen 96.7% since, to $296 in 2025.
Across 41 payments — averaging $226.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Organox Ltd$217
- Takeda Pharmaceuticals U.S.A., Inc.$125
- Lexicon Pharmaceuticals, Inc.$125
- Novartis$77
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$69
What the payments were for
- Travel & lodging$3,85942%
- Food & beverage$1,40715%
- Education$4,00043%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 30 | $8,663 |
| Organox Ltd | 3 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| Novartis | 5 | $77 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,316
- DAVINCI XI$4,000
- LIVTENCITY$125
- Inpefa$125
How this compares
$9,275 in reported general payments places this provider in the 75th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 56 | $14,630 |
| Atovaquone | 36 | $10,907 |
| Mycophenolate Mofetil | 16 | $6,631 |
| Entecavir | 13 | $3,009 |
| Tacrolimus | 20 | $2,928 |
| Ursodiol | 35 | $1,715 |
| Pantoprazole Sodium | 78 | $351 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 51 | $212 |
| Tamsulosin Hcl | 26 | $179 |
| Nifedipine ErNifedipine | 20 | $111 |
| Levetiracetam | 15 | $111 |
| Prednisone | 25 | $105 |
| Quetiapine Fumarate | 18 | $38 |
| Carvedilol | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Manhasset
- Johanna MedinaManhasset$315
- Roberto Hernandez AlejandroRochester$524K
- Tejinder SinghAlbany$513K
- Kishore IyerNew York$95K
- Jason HawksworthNew York$91K
- Parissa TabrizianNew York$74K
- Koji TomiyamaRochester$36K
- Lloyd RatnerNew York$32K
- Hautien LiouNew York$31K
- Karim HalazunNew York$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.